Provided by Tiger Fintech (Singapore) Pte. Ltd.

TransCode Therapeutics Inc.

0.8148
+0.03484.46%
Pre-market: 0.7600-0.0548-6.73%04:28 EDT
Volume:1.76M
Turnover:1.39M
Market Cap:567.30K
PE:-0.01
High:0.8468
Open:0.8000
Low:0.7500
Close:0.7800
Loading ...

Transcode Therapeutics Price Target Maintained With a $20.00/Share by HC Wainwright & Co.

Dow Jones
·
13 Mar

TransCode Therapeutics Says Safety Review Committee Approves Opening of Fourth Group in Phase 1 Trial to Treat Metastatic Cancers

MT Newswires Live
·
13 Mar

Transcode Therapeutics’ fourth cohort in Phase 1/2 cancer trial approved

TIPRANKS
·
13 Mar

TransCode Therapeutics Announces Safety Review Committee Approval to Open Fourth Cohort in Phase I/II Clinical Trial

PR Newswire
·
13 Mar

TransCode Therapeutics, Inc. Announces Results of Special Meeting

PR Newswire
·
26 Feb

Nasdaq Dips 1.5%; Home Depot Issues Weak Forecast

Benzinga
·
26 Feb

Transcode Therapeutics Inc trading resumes

TIPRANKS
·
22 Feb

Top Midday Gainers

MT Newswires Live
·
07 Feb

Transcode Therapeutics Price Target Maintained With a $20.00/Share by HC Wainwright & Co.

Dow Jones
·
07 Feb

Promising Clinical Developments Drive Buy Rating for TransCode Therapeutics

TIPRANKS
·
06 Feb

Transcode Therapeutics Announces Completion of Cohort 3 Initial Dosing With Lead Candidate in Phase 1 Clinical Trial

THOMSON REUTERS
·
06 Feb

TransCode Therapeutics Announces Completion of Cohort 3 Initial Dosing with Lead Candidate in Phase 1 Clinical Trial

PR Newswire
·
06 Feb

Transcode Therapeutics Inc trading halted, volatility trading pause

TIPRANKS
·
05 Feb

TransCode Therapeutics, Inc. Announces Adjournment of Special Meeting and Information for Adjourned Special Meeting

PR Newswire
·
05 Feb

Transcode Therapeutics Inc trading halted, volatility trading pause

TIPRANKS
·
28 Jan

Transcode Therapeutics Inc trading halted, volatility trading pause

TIPRANKS
·
24 Jan